Search

A recent study conducted by researchers at the University of Georgia College of Pharmacy focuses on the challenges of managing antiretroviral therapy (ART) in the intensive care unit (ICU) for critically ill individuals with HIV/AIDS. The study found that people with HIV have a 50% higher risk of ICU admission, often for non-HIV-related conditions. The researchers emphasize the complexity of selecting appropriate ART in the ICU due to drug interactions, absorption issues, and dosing adjustments. They suggest that with careful consideration, continuation of ART in the ICU is often feasible through dose adjustments or alternative administration methods, but temporary discontinuation may be beneficial depending on the clinical scenario. The study aims to identify strategies for addressing these challenges and improving care and outcomes for critically ill individuals with HIV/AIDS. [Extracted from the article]

The University of Virginia conducted research on HIV/AIDS and the impact of health insurance plans on access to preventive care, particularly pre-exposure prophylaxis (PrEP). The study found that insurance plan designs vary significantly, with some plans facilitating access to preventive care while others restrict it. Geographic disparities in access to HIV preventive care were also identified, with certain states having more restrictive insurance clusters. The researchers emphasized the need for insurance plans to consider public health and health equity factors to ensure access to critical preventive services, especially for marginalized populations. [Extracted from the article]

A new report discusses research findings on managing antiretroviral therapy (ART) in the intensive care unit (ICU) for critically ill individuals with HIV/AIDS. The study highlights the challenges of selecting appropriate ART in the ICU due to drug interactions, absorption issues, and dosing adjustments. Continuation of ART in the ICU can be challenging, but with careful consideration, it is often feasible through dose adjustments or alternative administration methods. The review offers strategies for overcoming these challenges and optimizing ART in the ICU. [Extracted from the article]

A new report from the University of Virginia provides data on HIV-related opportunistic infections (OIs) in the United States from 2011 to 2018. The study analyzed hospitalization rates and in-hospital mortality rates associated with OIs among people with HIV (PWH). The research found that there were an estimated 1,710,164 hospital discharges for PWH during this period, with 9.2% of them associated with an OI. Factors associated with higher odds of OI-related hospitalizations included younger age, male sex, non-white race/ethnicity, and being uninsured. The study highlights the need for continued funding of HIV testing, health insurance for all PWH, OI screening initiatives, review of current prophylaxis guidelines, and recruitment of more HIV clinicians. [Extracted from the article]

Keywords: Antiretrovirals; Drugs and Therapies; HIV/AIDS; Health and Medicine; Immune System Diseases and Conditions; Legal Issues; Primate Lentiviruses; RNA Viruses; Retroviridae; Vertebrate Viruses; Viral Sexually Transmitted Diseases and Conditions EN Antiretrovirals Drugs and Therapies HIV/AIDS Health and Medicine Immune System Diseases and Conditions Legal Issues Primate Lentiviruses RNA Viruses Retroviridae Vertebrate Viruses Viral Sexually Transmitted Diseases and Conditions 131 131 1 05/08/23 20230508 NES 230508 2023 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Data detailed on HIV/AIDS have been presented. Antiretrovirals, Drugs and Therapies, HIV/AIDS, Health and Medicine, Immune System Diseases and Conditions, Legal Issues, Primate Lentiviruses, RNA Viruses, Retroviridae, Vertebrate Viruses, Viral Sexually Transmitted Diseases and Conditions. [Extracted from the article]